Strategy Down Month: Dead Money or Big Opportunity
Strategy stock has fallen 46% in a single month as Bitcoin declines, prompting a split in investor views: is this dea...
Knowing when to assess your retirement strategy ensures your financial plan remains effective. Regular evaluations can lead to better outcomes.
21,973 articlesStrategy stock has fallen 46% in a single month as Bitcoin declines, prompting a split in investor views: is this dea...
As biotech investors digest Recursion's latest quarterly results, this Deep Dive breaks down what recursion (rxrx) 20...
When a cybersecurity giant bets $25 billion on a single platform, investors should understand the why, the potential ...
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Pfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
As Walmart introduces a new chief executive in 2026, investors weigh whether the company can sustain growth, expand m...
Institutional activity in Bitcoin ETFs is more nuanced than daily inflows suggest. This piece examines how market mak...
As Cricut reports its 2025 earnings, investors weigh growth engines, profitability, and strategic bets. This guide br...
Earnings calls reveal the health of specialized housing providers. This guide breaks down how to interpret target hos...
A quiet revolution is unfolding in AI infrastructure. This article explains why the stock market underestimating mass...
Investors often wonder if a smaller company can replicate Berkshire Hathaway’s long-term success. This analysis looks...
A biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...